133 related articles for article (PubMed ID: 1780043)
21. Amelioration of naloxone-precipitated opioid withdrawal symptoms by peripheral administration of the enkephalinase inhibitor acetorphan.
Livingston SJ; Sewell RD; Rooney KF; Smith HJ
Psychopharmacology (Berl); 1988; 94(4):540-4. PubMed ID: 3131801
[TBL] [Abstract][Full Text] [Related]
22. In vivo 'enkephalinase' inhibition by acetorphan in human plasma and CSF.
Spillantini MG; Geppetti P; Fanciullacci M; Michelacci S; Lecomte JM; Sicuteri F
Eur J Pharmacol; 1986 Jun; 125(1):147-50. PubMed ID: 3015640
[TBL] [Abstract][Full Text] [Related]
23. Effects of an enkephalinase inhibitor on esophageal motility in man.
Chaussade S; Hamm R; Lecomte JM; Couturier D; Guerre J
Gastroenterol Clin Biol; 1988 Nov; 12(11):793-6. PubMed ID: 3220232
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of apomorphine-induced yawning and penile erection by neurotensin.
Nouel D; Costentin J
Peptides; 1991; 12(4):755-9. PubMed ID: 1788138
[TBL] [Abstract][Full Text] [Related]
25. Effects of acetorphan, an enkephalinase inhibitor, on experimental and acute diarrhoea.
Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
Gut; 1992 Jun; 33(6):753-8. PubMed ID: 1624154
[TBL] [Abstract][Full Text] [Related]
26. A C-terminal cyclic 8-13 neurotensin fragment analog appears less exposed to neprilysin when it crosses the blood-brain barrier than the cerebrospinal fluid-brain barrier in mice.
Van Kemmel FM; Dubuc I; Bourdel E; Fehrentz JA; Martinez J; Costentin J
Neurosci Lett; 1996 Oct; 217(1):58-60. PubMed ID: 8905739
[TBL] [Abstract][Full Text] [Related]
27. Non-cholinergic neural excitation of the human rectum induced by acetorphan, an inhibitor of enkephalinase.
Grimaud JC; Bouvier M; Naudy B; Salducci J
Gastroenterol Clin Biol; 1989 Oct; 13(10):799-803. PubMed ID: 2591688
[TBL] [Abstract][Full Text] [Related]
28. [Anti-arrhythmia effects of enkephalinase inhibitors].
Lishmanov IuB; Maslov LN; Uskina EV
Eksp Klin Farmakol; 2001; 64(5):28-30. PubMed ID: 11764494
[TBL] [Abstract][Full Text] [Related]
29. Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and humans.
Lecomte JM; Baumer P; Lim C; Duchier J; Cournot A; Dussaule JC; Ardaillou R; Gros C; Chaignon B; Souque A
Eur J Pharmacol; 1990 Apr; 179(1-2):65-73. PubMed ID: 2163851
[TBL] [Abstract][Full Text] [Related]
30. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
Marçais-Collado H; Uchida G; Costentin J; Schwartz JC; Lecomte JM
Eur J Pharmacol; 1987 Dec; 144(2):125-32. PubMed ID: 3481337
[TBL] [Abstract][Full Text] [Related]
31. [Acetorphan, a potent enkephalinase inhibitor, does not modify orocecal and colonic transit times in healthy subjects].
Baumer P; Akoué K; Bergmann JF; Chaussade S; Nepveux P; Alexandre CL; Schwartz JC; Lecomte JM
Gastroenterol Clin Biol; 1989 Nov; 13(11):947-8. PubMed ID: 2612837
[No Abstract] [Full Text] [Related]
32. Naloxone-reversible inhibition of gall-bladder mucosal fluid secretion in experimental cholecystitis in the cat by acetorphan, an enkephalinase inhibitor.
Jivegård L; Pollard H; Moreau J; Schwartz JC; Thune A; Svanvik J
Clin Sci (Lond); 1989 Jul; 77(1):49-54. PubMed ID: 2758762
[TBL] [Abstract][Full Text] [Related]
33. Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan.
Gros C; Souque A; Schwartz JC; Duchier J; Cournot A; Baumer P; Lecomte JM
Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7580-4. PubMed ID: 2529543
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats.
Kita A; Imano K; Seto Y; Yakuo I; Deguchi T; Nakamura H
Jpn J Pharmacol; 1997 Dec; 75(4):337-46. PubMed ID: 9469639
[TBL] [Abstract][Full Text] [Related]
35. [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea].
Baumer P; Danquechin Dorval E; Bertrand J; Vetel JM; Schwartz JC; Lecomte JM
Ann Gastroenterol Hepatol (Paris); 1992; 28(6-7):279-85. PubMed ID: 1285638
[No Abstract] [Full Text] [Related]
36. [Treatment of acute chemically induced diarrhea by inhibition of enkephalinase. Results of a pilot study].
Dorval ED; Regimbeau C; Gamelin E; Picon L; Bérard H
Gastroenterol Clin Biol; 1995 Jan; 19(1):27-30. PubMed ID: 7720986
[TBL] [Abstract][Full Text] [Related]
37. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC
J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620
[TBL] [Abstract][Full Text] [Related]
38. The enkephalinase inhibitor, acetorphan, in acute diarrhoea. A double-blind, controlled clinical trial versus loperamide.
Roge J; Baumer P; Berard H; Schwartz JC; Lecomte JM
Scand J Gastroenterol; 1993 Apr; 28(4):352-4. PubMed ID: 8488368
[TBL] [Abstract][Full Text] [Related]
39. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity.
Hachisu M; Takahashi H; Hiranuma T; Shibazaki Y; Murata S
J Pharmacobiodyn; 1985 Sep; 8(9):701-10. PubMed ID: 3910797
[TBL] [Abstract][Full Text] [Related]
40. Action of enkephalinase (EC 3.4.24.11) inhibition on the pre- and post-prandial electromyographic patterns of colon in rats.
Benouali S; Berard H; Roche M
Neuropeptides; 1993 May; 24(5):299-305. PubMed ID: 8392143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
